ArticlePoultry science2026
Whole-genome insights into a multidrug-resistant, biofilm-forming, and pathogenic Salmonella Umbilo isolate and molecular characterization of rare Salmonella serovars from poultry.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Salmonellosis is one of the leading foodborne zoonoses worldwide, with contaminated poultry products representing a major source of human infection. This study characterized rare Salmonella serovars circulating in poultry flocks with respect to biofilm formation, virulence, antimicrobial resistance (AMR), CRISPR loci diversity, and genomic features. Salmonella isolates were conventionally isolated from drug swap samples and serotyped. Biofilm- (csgA, csgB, csgD, ompR, adrA, rpoS, and fimH) and virulence-associated genes (sipA, sipD, sopB, sopD, sopE, sopE2, sitC, sifA, ssaR, spvC, and pefA) were investigated. CRISPR loci and phenotypic AMR were examined. The Salmonella isolate, which exhibited the highest MAR index, was analyzed by whole-genome sequencing (WGS). Bioinformatic analyses were conducted to determine its plasmid, AMR, and virulence capacity. Thirty rare Salmonella serovars were identified including, Aba, Atento, Ball, Blegdam, Bonariensis, Bradford, Chandans, Fallowfield, Ferruch, Idikan, II (1,9,12:g,m,s,t:e,n,x), Inganda, Korbol, Leeuwarden, Menden, Naestved, Ohlstedt, Papuana, Petahtikve, Sandow, Schwarzengrund, Svedvi, Telaviv, Thompson, Tinda, Tsevie, Tumodi, Umbilo, Uppsala, and Vejle. CsgA-B-C (100.0%) and sipA (96.7%) were the most prevalent genes. S. Sandow harbored all examined genes. CRISPR2 locus (23.3%) was more prevalent than the CRISPR1 locus (3.3%). Resistance to streptomycin (56.7%) and sulfonamides (46.7%) was most common, whereas 40.0% of the isolates were MDR. WGS of the S. Umbilo isolate, which exhibited the highest MAR index (0.48), identified the IncHI2A plasmid (a key factor in horizontal transfer of AMR genes), 12 AMR genes (responsible for resistance to beta-lactams, aminoglycosides, phenicols, and lincosamides), and 181 virulence-associated genes (involved in adhesion, invasion, chemotaxis, intracellular survival, and environmental persistence). The detection of highly resistant and potentially pathogenic S. Umbilo, previously linked to a multinational foodborne outbreak in Europe, highlights its potential public health significance. MLST further proved useful for serovar prediction, with ST2014. Rare Salmonella serovars circulating in poultry flocks possess substantial virulence, biofilm-forming, and AMR potential. These findings highlight the importance of including rare serovars in surveillance and control programs to mitigate foodborne transmission and the spread of AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.